AbbVie Inc. enters the obesity market with GUBamy, a promising amylin analog. Click here to find out why ABBV stock is a Buy.
Novo Nordisk (NVO), the company behind popular diabetes and obesity treatments Ozempic and Wegovy, saw its stock rise on Thursday after ...
Novo Nordisk (NVO) stock rebounds after Kepler Cheuvreux upgrades to Buy following a 42% stock drop over the past year. Read ...
Zealand-aktien dykker kraftigt – Novo stigerOpdateret kl. 09.47. Københavns Fondsbørs har skudt gang i handlen torsdag, hvor ...
The Novo Nordisk Foundation and University of Copenhagen researchers have backtracked over a project to redefine how the ...
Over the past few days, as the rest of the stock market melted down, a revolution has been quietly brewing in the market for ...
Shares of Novo Nordisk and Eli Lilly slipped in premarket trading Wednesday after Roche said it had landed a $5.3 billion ...
Novo Nordisk released the results from its late-stage trial of CagriSema on Monday. It showed that patients on the highest dose of the drug lost 15.7% of their weight.
Information forklarer klimaet er en ugentlig podcast, der dykker ned i de vigtigste begreber inden for grøn omstilling, ...
Et strømsvigt i hovedstaden er lige nu årsag til, at du formentlig ikke kan se særlig meget, hvis du går ind i en butik på Københavns Hovedbanegård.
Når grønlænderne på tirsdag skal til stemmeurnerne og sætte deres kryds, vil der være langt flere mandlige end kvindelige ...
Til Ekstra Bladet oplyser direktør Lars Bork Hansen fra Novos underleverandør Norisol, at man stadig bruger den omstridte certificerede partner til at skaffe udenlandsk arbejdskraft. Og det vil man ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback